from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2591/PE_PGRS44

LFCtreatmentdescriptionclass of inhibitor

0.046

Amikacinug/mL Amikacintranslation

-2.425

Cap5-10ug/mL Capreomycintranslation

-0.933

Rox10-50 ug/mL Roxithromycintranslation

-0.205

SM2-5 ug/mL Streptomycintranslation

-1.142

Tet5-10 ug/mL Tetracyclinetranslation

-0.627

Rif0.2-5ug/mL Rifampicintranscription

-3.435

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.172

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.432

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.268

CPZ10-50 ug/mL Chlorpromazinerespiration

0.344

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.598

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.789

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.048

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.448

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.454

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.290

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.313

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.327

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.252

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.451

KCN5-20 ug/mL Potassium cyaniderespiration

0.749

NaN30.2-2 mM Sodium aziderespiration

0.637

Nigericin50 uM Nigericinrespiration

-0.434

TRC10-150 ug/mL Triclosanrespiration

-0.422

TRZ10-25 ug/mL Thioridazinerespiration

-1.496

Valinomycin0.5-10 uM Valinomycinrespiration

0.522

ZnSO42 mM ZnSO4respiration

0.556

menadione6-10 ug/mL Menadionerespiration

0.469

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.533

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.021

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.053

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.762

NRP_1Non-replicating persistence stage 1dosRassociated

-0.197

Amp0.2mg/mL AmpicillincellWall

0.003

Cephalexin20-100 ug/mL CephalexincellWall

-0.723

Cerulenin0.32-5 ug/mL CerulenincellWall

0.657

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.325

EMB10-20 ug/mL EthambutolcellWall

-0.378

Eta12-40 ug/mL EthionamidecellWall

0.258

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.451

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.818

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.204

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.154

BZA0.12 mg/mL BenzamidearomaticAmides

0.459

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.936

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.448

H2O24 mM hydrogen peroxideDNAdamaging

-1.197

Levo10 ug/mL LevofloxacinDNAdamaging

0.164

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.575

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.489

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.468

UVUV-irradiationDNAdamaging

-0.804

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.634

Antimycin12.5-50 ug/mL Antimycin A?

0.194

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.243

PA_110-50 ug/mL Antitubercular compound PA-1?

0.037

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.544

PA8240.2-2 ug/mL PA-824?

0.698

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.520

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.131

Verapamil50 uM Verapamil?

0.474

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.225

methoxatin10-20 ug/mL Methoxatin?